| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |